Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alfredo Antonaci is active.

Publication


Featured researches published by Alfredo Antonaci.


PLOS ONE | 2012

Q-elastography in the presurgical diagnosis of thyroid nodules with indeterminate cytology.

Vito Cantisani; Salvatore Ulisse; Guaitoli E; Corrado De Vito; Riccardo Caruso; Renzo Mocini; Vito D’Andrea; Valeria Ascoli; Alfredo Antonaci; Carlo Catalano; Francesco Nardi; Adriano Redler; Paolo Ricci; Enrico De Antoni; Salvatore Sorrenti

Quantitative ultrasound (US) elastography (Q-USE), able to evaluate tissue stiffness has been indicated as a new diagnostic tool to differentiate benign from malignant thyroid lesions. Aim of this prospective study, conducted at the Department of Surgical Sciences, of the “Sapienza” University of Rome, was to evaluate the diagnostic accuracy of Q-USE, compared with US parameters, in thyroid nodules with indeterminate cytology (Thy3).The case study included 140 nodules from 140 consecutive patients. Patient’s thyroid nodules were evaluated by Q-USE, measuring the strain ratio (SR) of stiffness between nodular and surrounding normal thyroid tissue, and conventional US parameters prior fine-needle aspiration cytology. Those with Thy3 diagnosis were included in the study. Forty of the nodules analyzed harbored a malignant lesion. Q-USE demonstrated that malignant nodules have a significant higher stiffness with respect to benign one and an optimun SR cut-off value of 2.05 was individuated following ROC analysis. Univariate analysis showed that hypoechogenicity, irregular margins and SR >2.05 associated with malignancy, with an accuracy of 67.2%, 81,0% and 89.8%, respectively. Data were unaffected by nodule size or thyroiditis. These findings were confirmed in multivariate analysis demonstrating a significant association of the SR and the irregular margins with thyroid nodule’s malignancy. In conclusion, we demonstrated the diagnostic utility of Q-USE in the differential diagnosis of thyroid nodules with indeterminate cytology that, if confirmed, could be of major clinical utility in patients’ presurgical selection.


Journal of Neuro-oncology | 2001

Single brain metastasis from thyroid cancer: Report of twelve cases and review of the literature

Maurizio Salvati; Alessandro Frati; Giovanni Rocchi; Raffaele Masciangelo; Alfredo Antonaci; Franco Maria Gagliardi; Roberto Delfini

Brain metastases from thyroid carcinoma is unusual, with a frequency of 1%.We report twelve patients, with single brain metastases and with a karnofsky performance scale score ≥60 at admission. No metastasis was seen during the uptake of iodine-131, even in the cases from differentiated thyroid carcinoma, suggesting absence of differentiation between primary and metastasic disease. The histopathology of thyroid carcinomas was anaplastic in five cases, differentiated in six, and medullary in one. Only in four patients, brain was the unique site of metastatic spread; in others, bones and lungs were also involved. All metastases were surgically removed, and all patients were treated with radiotherapy (45 Gy) in the postoperative course. The survival average was 19.8 months, and the quality of life was satisfactory in all patients. One patient remained alive till 5 years. Anaplastic histopathology and size of the primitive, and also bone involvement of thyroid disease were significant risk factors in our cases (p ≤ 0.05). According to the literature, surgery is the best therapeutical choice. Alternative strategies in the management of brain metastasis, such as iodine-131 therapy, are discussed, paying particular attention to the relevant side effects.


Oncology Research | 2009

Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma.

Alfredo Antonaci; Fabrizio Consorti; Stefania Mardente; Gloria Giovannone

The association between chronic lymphocytic thyroiditis and papillary thyroid carcinoma has been investigated for several years from different perspectives but with few attempts to design a common frame of reference to understand the complex mutual interactions between the various pathways of inflammatory response and of thyroid tumor induction and progression. This article reviews the current knowledge and research on this topic according to epidemiologic, immunobiologic, pathologic, and biomolecular points of view, highlighting achievements and lack of knowledge. It draws some conclusions and points at possible future directions for research.


European Surgical Research | 2010

Risk of Malignancy from Thyroid Nodular Disease as an Element of Clinical Management of Patients with Hashimoto’s Thyroiditis

Fabrizio Consorti; M. Loponte; Francesca Milazzo; L. Potasso; Alfredo Antonaci

Background: Many studies have investigated the association between chronic lymphocytic thyroiditis (CLT) and papillary thyroid carcinoma (PTC), but clinical management of this condition has never been addressed specifically, even in recent guidelines. Surprisingly the likelihood of a nodule as being cancerous in a CLT has never been explicitly expressed in terms of relative risk. Methods: This study was based on a retrospective analysis of 404 patients undergoing total thyroidectomy. Results: Sixty-nine patients (17.1%) had histological findings of true CLT, and 36.2% had concurrent PTC versus 22.6% of patients in the non-CLT group (p < 0.05), with a tumour risk in the CLT group of ×1.6 (95% CI = 1.21–1.94, likelihood ratio = +1.63). Conclusions: Patients with CLT and a nodular condition have a ×1.6 increased risk of harbouring a PTC. Moreover, these patients develop multicentric PTC more frequently, and, as a result, total thyroidectomy should always be considered.


World Journal of Surgical Oncology | 2011

Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer

Fabrizio Consorti; Gianluca Di Tanna; Francesca Milazzo; Alfredo Antonaci

BackgroundMany studies have reported an increased risk of developing a second primary malignancy (SPM) of the breast in women treated for thyroid cancer. In this study, we investigated several potential risk factors for this association. The aim of this retrospective cohort study was to identify a subgroup of women surgically treated for papillary thyroid cancer that may benefit from more careful breast cancer screening.MethodsA total of 101 women surgically treated for papillary thyroid cancer from 1996 to 2009 with subsequent follow-up were interviewed by phone regarding personal risk factors and lifestyle habits. Only 75 questionnaires could be evaluated due to a 25.7% rate of patients not retrieved or refusing the interview. Data analysis was performed using a multivariate logistic model.ResultsThe standardised incidence ratio (SIR) for breast cancer was 3.58 (95% IC 1.14 - 8.37). Our data suggest a protective effect of multiparity on the development of a SPM of the breast (O.R. 0.15; 95% IC 0.25 - 0.86). Significant associations were not found with other known risk factors including Body Mass Index (BMI), age at first tumour, concurrent metabolic diseases, smoking, physical activity and familiarity.ConclusionsThis study confirms that a higher incidence of SPM of the breast is observed in women treated for papillary thyroid cancer. Additionally, this risk is increased by nulliparity, thus a strict breast screening program for nulliparous women treated for thyroid cancer may be advisable.


BMC Surgery | 2015

Frequency and severity of globus pharyngeus symptoms in patients undergoing thyroidectomy: a pre-post short term cross-sectional study

Fabrizio Consorti; Rosaria Mancuso; Valentina Mingarelli; Eugenio Pretore; Alfredo Antonaci

BackgroundGlobus pharyngeus is a sensation of a lump or foreign body in the throat, sometimes associated with thyroid diseases and surgery. Previous studies investigated this condition with contradictory results, mainly because not standardized instruments of measure were used. The aim of this study was to evaluate the prevalence and severity of globus pattern symptoms in a population of patients three months after a thyroidectomy, and the reduction or increase of pre-existing symptoms or the onset of new symptoms.MethodsNinety-five patients (65 women, 30 men, mean age 56.03 ± 12.45) were assessed for globus pattern symptoms before and three months after thyroid surgery (72 patients: benign goiter, 23 patients: papillary cancer). The Glasgow-Edinburgh Throat Scale (GETS) was translated into Italian and used as a validated instrument of measure of the severity of globus pattern symptoms.ResultsThe Italian version of the GETS was reliable (Cronbach alpha = 0.85) and valid. Normative data were used to classify patients into 4 groups of severity. A significant decrease of the mean GETS score was observed at the postoperative assessment (13.02 ± 11.84 vs 8.00 ± 11.26; p < 0.01), but beside symptomatic patients who improved we could observe also two other significant groups of patients: asymptomatic patients who developed symptoms and symptomatic patients who remained symptomatic.ConclusionsThe significant decrease of the mean GETS postoperative score was mainly due to the improvement of strongly symptomatic patients. Two other significant outcomes exist and further studies are needed to understand their pathophysiological mechanism.


BMC Surgery | 2012

Factors influencing the length of the incision and the operating time for total thyroidectomy.

Fabrizio Consorti; Francesca Milazzo; Mariagiovanna Notarangelo; Laura Scardella; Alfredo Antonaci

BackgroundThe incision used for thyroid surgery has become shorter over time, from the classical 10 cm long Kocher incision to the shortest 15 mm access achieved with Minimally Invasive Video-Assisted Thyroidectomy. This rather large interval encompasses many different possible technical choices, even if we just consider open surgery.The aim of the study was to assess the correlation between incision length and operation duration with a set of biometric and clinical factors and establish a rationale for the decision on the length of incision in open surgery.MethodsNinety-seven consecutive patients scheduled for total thyroidectomy were prospectively evaluated. All operations were performed by the same team and the surgeon decided the length of the incision according to his personal judgement. Patients who had previously undergone neck surgery were excluded.ResultsThe length of the incision was strongly correlated with gender, thyroid volume, neck circumference and clinical diagnosis and weakly correlated with the body mass index. Operation duration was only weakly correlated with gender and neck circumference. Multiple linear regression revealed that the set of factors assessed explained almost 60 % of the variance in incision length but only 20 % of the variance in operation duration. When patients were classified according to the distribution of their thyroid volume, cases within one standard deviation of the mean did not show a significant difference in terms of operation duration with incisions of various lengths.ConclusionsAlthough thyroid volume was a major factor in driving the decision with respect to the length of the incision, our study shows that it had only minor effect on the duration of the operation. Many more open thyroidectomies could therefore be safely performed with shorter incisions, especially in women. Duration of the operation is probably more closely linked to the inherent technical difficulty of each case.


Oncology Reports | 2012

HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells.

Stefania Mardente; Emanuela Mari; Fabrizio Consorti; Cira Di Gioia; Rodolfo Negri; Marilena P. Etna; Alessandra Zicari; Alfredo Antonaci


Oncology Reports | 2008

Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma

Alfredo Antonaci; Fabrizio Consorti; Stefania Mardente; Stefania Natalizi; Gloria Giovannone; Carlo Della Rocca


Oncology Reports | 2010

Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer

Stefania Mardente; Alessandra Zicari; Fabrizio Consorti; Emanuela Mari; Maura Di Vito; Martina Leopizzi; Carlo Della Rocca; Alfredo Antonaci

Collaboration


Dive into the Alfredo Antonaci's collaboration.

Top Co-Authors

Avatar

Fabrizio Consorti

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Stefania Mardente

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Carlo Della Rocca

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Francesca Milazzo

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Alessandra Zicari

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Emanuela Mari

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Adriano Redler

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Alessandro Frati

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Carlo Catalano

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Cira Di Gioia

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge